月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
只接受综述和邀请评论(评论和邀请评论)。由现代医药集团有限责任公司出版。ISSN(印刷):1523-3804。ISSN(电子):1534 - 6242。本杂志的目的是系统地为当前动脉粥样硬化领域的基础科学和临床进展提供专家意见，并强调可能改变心血管预防、诊断和治疗领域的最重要的发展。为了达到这一目标，我们任命了一些主要的权威机构作为栏目编辑，他们从世界各地挑选顶尖的专家，对过去一年发表的关键主题和论文进行权威的评论。我们还提供该领域知名人士的补充评论。一个由国际不同成员组成的编辑委员会建议他们的国家/地区特别感兴趣的主题，并确保主题是当前的，包括新兴的研究。
只接受综述和邀请评论（Reviews and Invited Commentaries）。Published by Current Medicine Group LLC. ISSN (printed): 1523-3804. ISSN (electronic): 1534-6242.The aim of this journal is to systematically provide expert views on current basic science and clinical advances in the field of atherosclerosis and highlight the most important developments likely to transform the field of cardiovascular prevention, diagnosis, and treatment. We accomplish this aim by appointing major authorities to serve as Section Editors who select leading experts from around the world to provide definitive reviews on key topics and papers published in the past year. We also provide supplementary reviews and commentaries from well-known figures in the field. An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.
